M. Schultze, A. Marijam, M. Pignot, A. Krinner, N. Kossack, F.S. Mitrani-Gold, A. Joshi.
Recurrence, healthcare resource use, and costs in the treatment of uncomplicated urinary tract infection in female patients in Germany.
European Congress of Clinical Microbiology and Infectious Diseases 15-18. April 2023 Copenhagen.
No DOI/URL available
Therapy areas:
Urology
Indications:
Urinary Tract Infection
Klein AB, Shire N, Winget M, Wang H, Wilk A, Pignot M.
Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database.
Value in Health 2017 VOLUME 20, ISSUE 9, PA473.
DOI:https://doi.org/10.1016/j.jval.2017.08.423
Therapy areas:
Oncology/Hematology
Indications:
Urothelial, Head And Neck, Non-Small Cell Lung Cancer
O'Kelly, J., Bartsch, R., Kossack, N., Borchert, J., Pignot, M. & Hadji, P. (2020).
Real-World Effectiveness of Osteoporosis Treatments in Germany.
Value in Health, 23, Artikel S592.
DOI:https://doi.org/10.1111/ddg.14021 (abgerufen am 06.12.2023).
Indications:
Osteoporosis
Kossack N, Schoenfelder T, Schultze M, Pignot M, Mehta S, Nazareth T, Walzer S.
Real-World Cost Difference in Patients With Psoriasis Initiating Apremilast vs. Secukinumab After Conventional Systemic Therapy Using German Sickness Fund Data.
DDK KOMPAKT 2020. JDDG Volume 18 Issue S1. 2020.
DOI: https://doi.org/10.1111/ddg.14021
Therapy areas:
Dermatology
Indications:
Psoriasis
Kossack N, Schoenfelder T, Schultze M, Pignot M, Mehta S, Nazareth T, Walzer S.
Real-World Cost Difference in Patients with Psoriasis Newly Initiating Apremilast vs. Biologic Treatment after Conventional Systemic Therapy: A Retrospective Analysis of German Sickness Fund Data.
Value in Health 2019 (22),
DOI: doi.org/10.1016/j.jval.2019.09.2645
Therapy areas:
Dermatology
Indications:
Psoriasis
James O‘Kelly , Robert Bartsch, Nils Kossack, Julia Borchert, Marc Pignot, Peyman Hadji.
Real-world effectiveness of osteoporosis treatments in Germany.
Arch Osteoporos 2022 Aug 31; 17(1): 119,
DOI: 10.1007/s11657-022-01156-z
Therapy areas:
Bone
Indications:
Osteoporosis
O’Kelly, J., Bartsch, R., Kossack, N., Borchert, J., Pinot, M. & Hadji, P. (2021).
Real-World Effectiveness of Osteoporosis Treatments in Germany.
Jahreskongress DVO OSTEOLOGIE 2021. Jahreskongress DVO OSTEOLOGIE 2021, 18.03 - 20.03.2021, Bremen. (Osteologie).
Georg Thieme Verlag KG. 02.11.2023).
Therapy areas:
Bone
Indications:
Osteoporosis
C. Vogelmeier , J. Nuevo , G. Telg , F.W. Friedrich , M. Pignot , F. Wiklund , C. Janson .
Real-Life Treatment Patterns and Burden of Disease Among Patients with COPD – A Large Observational Study.
American Journal of Respiratory and Critical Care Medicine 2020;201:A3331.
DOI: 10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3331
Therapy areas:
Respiratory
Indications:
COPD
Elena Garal-Pantaler; Michael Schultze; Mary Elizabeth Georgiou; Marc Pignot; Kerry Gairy; Jacob N Hunnicutt.
Real-world burden of immunosuppressant-treated lupus nephritis: a German claims database analysis.
Rheumatol Ther 25 November 2023,
https://doi.org/10.1007/s40744-023-00623-4
Therapy areas:
Immunology
Indications:
Lupus Nephritis
Jake N Hunnicutt, Michael Schultze, Elena Garal-Pantaler, Marc Pignot, Mary Elizabeth Georgiou, Kerry Gairy.
Prevalence of lupus nephritis among patients with systemic lupus erythematosus in Germany.
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May 2022,
https://doi.org/10.1093/ndt/gfac071.036
Therapy areas:
Immunology
Indications:
Lupus Nephritis
Kossack, N., Schönfelder, T., Schultze, M., Pignot, M., Mehta, S., Nazareth, T. & Walzer, S. (2019).
PSY17 REAL-WORLD COST DIFFERENCE IN PATIENTS WITH PSORIASIS NEWLY INITIATING APREMILAST VS. BIOLOGIC TREATMENT AFTER CONVENTIONAL SYSTEMIC THERAPY: A RETROSPECTIVE ANALYSIS OF GERMAN SICKNESS FUND DATA.
Value in Health, 22, S. S904.
DOI:https://doi.org/10.1016/j.jval.2019.09.2645 (abgerufen am 02.11.2023).
Therapy areas:
Dermatology
Indications:
Psoriasis
Zouboulis, C. C., Stein, A., Medelnik, J.-P., Heinrich, R., Galetzka, W., Borchert, J., Diesing, J. & Schönfelder, T. (2021).
Prevalence and Incidence of Adamantiades-Behçet’s Disease: An Epidemiological Study from Germany. [Vortrag].
Deutscher Rheumatologiekongress 2021, 49. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 35. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR). Deutsche Gesellschaft für Rheumatologie, Deutsche Gesellschaft für Orthopädische Rheumatologie & Gesellschaft für Kinder- und Jugendrheumatologie, 15.09.2021, virtuell.
DOI:https://doi.org/10.3205/21DGRH057 (abgerufen am 06.11.2023).
Therapy areas:
Immunology
Indications:
Behçet's disease
Häckl, D., Kossack, N. & Schönfelder, T. (2021).
Prävalenz, Kosten der Versorgung und Formen des dialysepflichtigen chronischen Nierenversagens in Deutschland: Vergleich der Dialyseversorgung innerhalb und außerhalb stationärer Pflegeeinrichtungen.
Das Gesundheitswesen, 83(10), S. 818–828. (Originaltitel „Prevalence, Costs of Medical Treatment and Modalities of Dialysis-dependent Chronic Renal Failure in Germany: Comparison of Dialysis Care of Nursing Home Residents and in Outpatient Units“).
DOI: https://doi.org/10.1055/a-1330-7152.
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Renal disease
Schindler, C., Kossack, N., Weinhold, I. & Häckl, D. (2017).
Posterior Capsule Opacification After Cataract Extraction And Related Healthcare Costs In Germany – A Claims Data Analysis On The Impact Of The Implanted Type Of Intraocular Lenses.
Value in Health, 20(9), S. A581.
DOI:https://doi.org/10.1016/j.jval.2017.08.1034 (abgerufen am 02.11.2023).
Therapy areas:
Ophthalmology
Indications:
Cataract
Schultze M, Zema C, Carroll R, Hurst M, Borchert J, Zhong Y, Krause T, Bluhmki T, Partington H.
Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany.
European Society of Cardiology (ESC) Congress 2022, 26–29 August 2022, Barcelona.
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Cardiomyopathy
Sprenger, R., Häckl, D., Kossack, N., Schiffner-Rohe, J., Wohlleben, J. & Eiff, C. von. (2022).
Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
PLoS ONE, 17(3), S. e0265433.
DOI:https://doi.org/10.1371/journal.pone.0265433 (abgerufen am 01.11.2023).
Therapy areas:
Infectious Diseases
Indications:
Pneumococcal disease
Sprenger, R., Häckl, D., Kossack, N., Schiffner-Rohe, J., Wohlleben, J. & Eiff, C. von. (2021).
Pneumococcal vaccination rates in immunocompromised patients in Germany: a retrospective cohort study to assess sequential vaccination rates and changes over time. [Preprint].
SSRN Electronic Journal, 17, S. 1–33.
DOI:https://doi.org/10.2139/ssrn.3934040 (abgerufen am 17.10.2023).
Therapy areas:
Bone
Indications:
Osteoporosis
O'Kelly, J., Bartsch, R., Kossack, N., Borchert, J., Pignot, M. & Hadji, P. (2020).
PMS3 Real-World Effectiveness of Osteoporosis Treatments in Germany.
Value in Health, 23, S. S592.
DOI:https://doi.org/10.1016/j.jval.2020.08.1134 (abgerufen am 02.11.2023).
Therapy areas:
Bone
Indications:
Osteoporosis
Borchert, J., Heinrich, R., Kock, S., Klaus, P., Dally, H., Hagemann, C., Diesing, J. & Schönfelder, T. (2022).
Prävalenz und Inzidenz der juvenilen idiopathischen Arthritis in Deutschland: Eine retrospektive Kohortenstudie basierend auf GKV-Abrechnungsdaten. In: Deutsche Gesellschaft für Rheumatologie, Deutsche Gesellschaft für Orthopädische Rheumatologie & Gesellschaft für Kinder- und Jugendrheumatologie (Hrsg.).
Deutscher Rheumatologiekongress 2022, 50. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 36. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 32. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR), 31.08.-03.09.2022, Berlin. Düsseldorf: Medical Science GMS Publishing House.
DOI:https://doi.org/10.3205/22dgrh146 (abgerufen am 20.10.2023).
Therapy areas:
Immunology
Indications:
Juvenile idiopathische arthritis
Hupe, M. C., Hammerer, P., Ketz, M., Kossack, N., Colling, C. & Merseburger, A. S. (2018).
PCN96 – INITIAL THERAPY FOR ADVANCED PROSTATE CARCINOMA (PCA) WITH A GNRH AGONIST (GNRHA) AND ANTAGONISTS – A RETROSPECTIVE ANALYSIS OF PRESCRIPTION PATTERNS AND HOSPITAL COSTS BASED ON GERMAN GKV [GESETZLICHE KRANKENVERSICHERUNG (STATUTORY HEALTH INSURANCE)] DATA.
Value in Health, 21, Artikel Supplement 3, S. S30-S31.
DOI:https://doi.org/10.1016/j.jval.2018.09.178 (abgerufen am 02.11.2023).
Therapy areas:
Oncology/Hematology
Indications:
Prostate cancer